Search - tctmd.com

Displaying 1 - 20 of 143

Sort: Relevancy | Date

News Daily News

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

Caitlin E. Cox

November 24, 2025

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

News Daily News

DAPT De-escalation Success Varies by Sex: Meta-analysis

Yael L. Maxwell

August 21, 2025

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Michael O'Riordan

July 03, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Daily News

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

Yael L. Maxwell

March 13, 2025

News Daily News

Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS

Yael L. Maxwell

March 10, 2025

News Daily News

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Yael L. Maxwell

January 23, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

Advertisement

Revascularization Decisions in the Elderly Require a Holistic Approach: AHA

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

DAPT De-escalation Success Varies by Sex: Meta-analysis

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Trade-offs With Invasive Strategy in Older Patients With ACS: Meta-analysis

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

Early Invasive Treatment May Help Highest-Risk Women With NSTE ACS

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Top Coronary Artery Disease News in 2024

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content